Kevin Freeman

Kevin Freeman

Chief Commercial OfficeratHealth Catalyst· In proxies 2022–2025

Pay in FY2025-16% from the year before · Health Catalyst stock -66.2% the same year

Kevin Freeman was paid $1.8M in FY2025 (Dec), down 16%. Health Catalyst stock fell 66.2% that year.

Pay$100 in the stock at the end of FY21 → $6
Pay is from the Summary Compensation Table of each Health Catalyst proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Health CatalystPublic company · 4 yr
    • Chief Commercial Officer2022 – Present · 4 yrStock in role -96%

Roles come from the proxy statements of each company.

Activity

Two people shown as one, or a wrong number?